AMENDMENT NO 2

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Fak7+KvWq00X513q9j70HJxHU60SM8Kf1QpZXlzyeciYV2R5ZRk0dv11HIGBSd6y 3d4VTNsA+ftD90xqzu7krw== 0000898286-03-000006.txt : 20030117 0000898286-03-000006.hdr.sgml : 20030117 20030117110618 ACCESSION NUMBER: 0000898286-03-000006 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20030117 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GENAISSANCE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001110009 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061338846 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59601 FILM NUMBER: 03517182 BUSINESS ADDRESS: STREET 1: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 2037731450 MAIL ADDRESS: STREET 1: FIVE SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CAISSE DE DEPOT ET PLACEMENT DU QUEBEC CENTRAL INDEX KEY: 0000898286 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 1981 AVE MCGILL COLLEGE STREET 2: MONTREAL QUEBEC CITY: CANADA STATE: E6 ZIP: H3A3C7 BUSINESS PHONE: 5148472130 SC 13D/A 1 g-13da.htm AMENDMENT NO 2 SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13DA
(Rule 13d-101)

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 3)

Genaissance Pharmaceuticals, Inc.
(Name of Issuer)

Common Shares
(Title of Class of Securities)

368 67W 105
(CUSIP Number)

Ginette Depelteau
Capital Technologies CDPQ inc.
(formely Sofinov, Société financière d'innovation inc.)
1981 McGill College Avenue, Montreal (Quebec), H3A 3C7
Tel.: (514) 847-5901
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

January 7, 2002
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7(b) for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Name Of Reporting Persons
I.R.S. Identification nos. of above persons (entities only)
Capital Technologies CDPQ inc. (formely Sofinov, Société financière d'innovation Inc.)
-------------------------------------------------------------------------------------------------------------
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------------------------------------
SEC USE ONLY
- -------------------------------------------------------------------------------------------------------------
Source of Funds (See Instructions)
WC
-------------------------------------------------------------------------------------------------------------
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ]
- -------------------------------------------------------------------------------------------------------------
Citizenship or Place of Organization
Montreal (Quebec) Canada
-------------------------------------------------------------------------------------------------------------
Sole Voting Power
1,091,590 Common Shares
-------------------------------------------------------------------------------------------------------------
Shares Voting Power
- -------------------------------------------------------------------------------------------------------------
Sole Dispositive Power
1,091,590 Common Shares
-------------------------------------------------------------------------------------------------------------
Shares Dispositive Power
- -------------------------------------------------------------------------------------------------------------
Aggregate Amount Beneficially Owned by Each Reporting Person
1,091,590 Common Shares
-------------------------------------------------------------------------------------------------------------
Check if the Aggregate Amount In Row (11) Excludes Certain Shares
(See Instructions) [ ]
- -------------------------------------------------------------------------------------------------------------
Percent of Class Represented by Amount in Row (11)
4.78%
-------------------------------------------------------------------------------------------------------------
Type of Reporting Person (See Instructions)
CO
-------------------------------------------------------------------------------------------------------------

Name Of Reporting Persons
I.R.S. Identification nos. of above persons (entities only)
Caisse de dépôt et placement du Québec
-------------------------------------------------------------------------------------------------------------
Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------------------------------------
SEC USE ONLY
- -------------------------------------------------------------------------------------------------------------
Source of Funds (See Instructions)
WC
-------------------------------------------------------------------------------------------------------------
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ]
- -------------------------------------------------------------------------------------------------------------
Citizenship or Place of Organization
Montreal (Quebec) Canada
-------------------------------------------------------------------------------------------------------------
Sole Voting Power
1,091,590 Common Shares
-------------------------------------------------------------------------------------------------------------
Shares Voting Power
- -------------------------------------------------------------------------------------------------------------
Sole Dispositive Power
1,091,590 Common Shares
-------------------------------------------------------------------------------------------------------------
Shares Dispositive Power
- -------------------------------------------------------------------------------------------------------------
Aggregate Amount Beneficially Owned by Each Reporting Person
1,091,590 Common Shares
-------------------------------------------------------------------------------------------------------------
Check if the Aggregate Amount In Row (11) Excludes Certain Shares
(See Instructions) [ ]
- -------------------------------------------------------------------------------------------------------------
Percent of Class Represented by Amount in Row (11)
4.78%
-------------------------------------------------------------------------------------------------------------
Type of Reporting Person (See Instructions)
CO
-------------------------------------------------------------------------------------------------------------

This Amendment No. 3, dated January 7, 2003 is being filed jointly on behalf of Caisse de dépôt et placement du Québec ("CDPQ") and by its wholly-owned subsidiary, Capital Technologies CDPQ inc. ("Capital") pursuant to Rule 13d-2(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to a Joint Filing Agreement dated January 7, 2003, between CDPQ and Capital, a copy of which is attached hereto as Exhibit A.

Item 1 - Security and Issuer

This statement is made with respect to the Common Shares (the "Shares") of Genaissance Pharmaceuticals, Inc. ("Genaissance"), a Connecticut corporation (the "Company"). The address of the principal executive offices of which is 5 Science Park, New Haven, Connecticut, U.S.A., 06511.

Item 2 - Identity and Background

This Schedule 13DA is filed jointly on behalf of CDPQ, a legal person without share capital and a mandatary of the State of the Province de Québec, created by a special act of the Legislature of the Province de Québec, and Capital, a legal entity duly incorporated under part 1A of the Companies ACT (Québec) and a wholly-owned subsidiary of CDPQ, pursuant to Rule 13d-1(f)(1) under the Exchange Act.

The principal business address and the principal office address of each of CDPQ and Capital is 1981, McGill College Avenue, Montréal, Québec, H3A 3C7. The names, business addresses and principal occupation of each director and executive officer of CDPQ and Capital are set forth in Exhibit B, attached hereto.

Each of the directors and executive officers named in Exhibit B is a Canadian citizen, except Mr. John T. Wall who is an American citizen.

To the best knowledge of CDPQ and Capital, none of the persons listed on Exhibit B has, during the last five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, United States federal or state securities laws or finding any violation with respect to such laws.

Item 3 - Source and Amount of Funds or Other Consideration

Capital sold 127,500 Shares for Can. $188,572.

Item 4 - Purpose of Transaction

Neither CDPQ nor Capital has any plans or proposals which relate to or would result in any of the actions or effects set forth in items (a) through (e) of Item 5 of Schedule 13DA, although either of them may develop such plans or proposals.

CDPQ and Capital intend to review on a continuing basis their investment in the Company. As of the date of this Schedule 13DA, no determination has been made by CDPQ or Capital to acquire additional shares of Common Stock or dispose of any shares of Common Stock now held by them, although either of them may decide to so acquire or dispose of shares of Common Stock. Any such determination will depend on market conditions prevailing from time to time and on other conditions which may be applicable depending on the nature of the transaction or transactions involved.

Item 5 - Interest in Securities of Issuer

With recent transactions, Capital is now the direct beneficial owner of 1,091,590 shares of Common Stock (the "Capital Shares"). CDPQ may be deemed to be the indirect, beneficial owner of the Capital Shares. The Capital Shares represent approximately 4.78% of the 22,847,000 shares of Common Stock of the Company outstanding on the date hereof, based upon information provided by the company.
CDPQ has the power to vote and dispose of the Capital Shares.
Except as set forth in this Schedule 13DA, none of CDPQ, Capital or, to the best knowledge of CDPQ or Capital, any person named on Exhibit B hereto, owns any shares of the Company's Common Stock, and none has purchased or sold any shares of the Company's Common Stock during the past 60 days.
Except as set forth in this Schedule 13DA, no person is known by CDPQ or Capital to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock of the Company beneficially owned by CDPQ and Capital.
Not applicable.

Item 6 - Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Except as set forth in this Schedule 13DA, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons referred to in Item 2 of this Schedule 13DA or between such persons and any other person with respect to any of the securities of the Company, including, but not limited to, any relating to the transfer or voting of any of such securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss or the giving or withholding of proxies.

Item 7 - Material to be Filed as Exhibits

Exhibit A: Joint Filing Agreement dated January 7, 2003 by and between Capital and CDPQ
Exhibit B: List of Executive Officers and Directors of CDPQ and Capital Technologies CDPQ inc.
Exhibit C: Joint Filing Table of Dates, Number of Shares sold and price per Share of Sales

After reasonable inquiry and to the best of my knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Signature

Date: January 7, 2003

Capital Technologies CDPQ inc.

Ginette Depelteau

-----------------------------------------------------------------------
Signature

Ginette Depelteau, Corporate Secretary
Name / Title

Caisse de dépot et placement du Québec

Ginette Depelteau

-----------------------------------------------------------------------
Signature

Ginette Depelteau, Vice-president and Corporate Secretary
Name / Title

EX-99 3 g-a.htm EXHIBIT A EXHIBIT A
Agreement

The undersigned hereby agree that this statement on Schedule 13D with respect to beneficial ownership of shares of common stock of Genaissance Pharmaceuticals, Inc. is filed jointly, on behalf of each of them.

Dated: January 7, 2003

Capital Technologies CDPQ inc.

By: Denis Dionne
Name: Denis Dionne
Title: President

By: Ginette Depelteau
Name: Ginette Depelteau
Title: Corporate Secretary

Caisse de dépot et placement du Québec

By: Claude Bergeron
Name: Claude Bergeron
Title: Vice-President, Legal Affairs

By: Ginette Depelteau
Name: Ginette Depelteau
Title: Vice-President and Corporate
Secretary

EX-99 4 g-b.htm DIRECTORS EXHIBIT B

LIST OF EXECUTIVE OFFICERS AND DIRECTORS

Capital Technologies CDPQ Inc.

DIRECTORS	BUSINESS ADDRESS	PRINCIPAL OCCUPATION
Henri-Paul Rousseau	Caisse de dépôt et placement du Québec 1981, avenue McGill College Montréal (Québec) H3A 3C7	Chairman and Chief Executive Officer
Jacques M. Brault	Financière Banque Nationale 1155, Metcalfe, 23^e étage Montréal (Québec) H3B 4S9	General Manager
Denis Dionne	Capital Technologies CDPQ Inc. 1981, avenue McGill College Montréal (Québec) H3A 3C7	President
Claude Lajeunesse	Ryerson Polytechnic University 350, Victoria Street Toronto (Ontario) H2M 2V1	President and Vice- Chancellor
Serge Martin	Martin International 500, Place d'Armes, Suite 2910 Montréal (Québec) H2Y 2W2	President
Guy Morneau	Régie des rentes du Québec 2600, boul. Laurier, bureau 546 Québec (Québec) G1V 4T3	Chairman of the Board and President
André Nadeau	CGI Group Inc. 1130, Sherbrooke West, 5th Floor Montreal (Quebec) H3A 2M8	Executive Vice-President and Chief Strategy Officer
Louis Brunel	Institut International des Télécommunications Place Bonaventure 800, de la Gauchetière Ouest, Suite 6700 Montréal (Québec) H5A 1K6	President and Chief Executive Office
Khalil Barsoum	30 Valentine Drive Toronto (Ontario) M3A 3J8

OFFICERS	BUSINESS ADDRESS	PRINCIPAL OCCUPATION
Henri-Paul Rousseau	Caisse de dépôt et placement du Québec 1981, avenue McGill College Montréal (Québec) H3A 3C7	Chairman and Chief Executive Officer
Denis Dionne	Capital Technologies CDPQ Inc. 1981, avenue McGill College Montréal (Québec) H3A 3C7	President
Ghislain Parent	Caisse de dépôt et placement du Québec 1981, avenue McGill College Montréal (Québec) H3A 3C7	Vice-President, Finance and Control
Ginette Depelteau	Same	Secretary

LIST OF EXECUTIVE OFFICERS AND DIRECTORS

CAISSE DE DÉPÔT ET PLACEMENT DU QUÉBEC

DIRECTORS	BUSINESS ADDRESS	PRINCIPAL OCCUPATION
Henri-Paul Rousseau	Caisse de dépôt et placement du Québec 1981, avenue McGill College Montréal (Québec) H3A 3C7	Chairman and Chief Executive Officer
Guy Morneau	Régie des rentes du Québec 2600, boul. Laurier, bureau 546 Québec (Québec) G1V 4T3	Chairman of the Board and President
Jean-Claude Bachand	Fraser Milner Casgrain 1, Place Ville-Marie Bureau 3900 Montréal (Québec) H3B 4M7	Lawyer
Bernard Bonin	745, Hot Springs Way Ottawa (Ontario) K1V 1W8
Claudette Carbonneau	Confédération des syndicats nationaux 1601, Delorimier Montréal (Québec) H2K 4M5	President
Alban D'Amours	Mouvement des caisses Desjardins 100, avenue des Commandeurs Lévis (Québec) G6V 7N5	President
Sylvie Dillard	Fonds québécois de la recherche sur la nature et les technologies 140, Grande-Allée Est, Bureau 450 Québec (Québec) G1R 5M8	Member and President of the board and Chief Executive Officer
Yves Filion	Hydro-Québec Distribution 75, boul. René-Lévesque Ouest Montréal (Québec) H2Z 1A4	President
Gilles Godbout	Ministère des Finances 12, rue St-Louis Québec (Québec) G1R 5L3	Deputy Minister, Finance, Economy and Research
Thomas O. Hecht	Technologies IBEX Inc. 5485, rue Paré Montréal (Québec) H4P 1P7	Chairman Emeritus
Henri Massé	Fédération des travailleurs et travailleuses du Québec 545, boul. Crémazie Est Montréal, (Québec) H2M 2V1	President
Nicole Trudeau	Commission municipale du Québec 500, René-Lévesque Blvd. West Suite 24.200 Montréal (Québec) H2Z 1W7	Vice-President
Duc Vu	Commission administrative des régimes de retraite et d'assurances 475, St-Amable Québec (Québec) G1R 5X3	President
John T. Wall	6601, Radnor Road Bethesda, Maryland 20817 USA

OFFICERS	BUSINESS ADDRESS	PRINCIPAL OCCUPATION
Henri-Paul Rousseau	Caisse de dépôt et placement du Québec 1981, avenue McGill College Montréal (Québec) H3A 3C7	Chairman and Chief Executive Officer
Fernand Perreault	Same	President, CDP Capital - Real Estate Group and Executive Vice-President, CDP Capital
Richard Guay	Same	Executive Vice-President, Risk Management and Depositors' Accounts Management, CDP Capital
Ghislain Parent	Same	Executive Vice-President, Finance and Administration, CDP Capital
Jean-Claude Cyr	Same	Executive Vice-President, Human Resources and Organizational Development CDP Capital
François Geoffrion	Same	Executive Vice-President, Strategic Development, CDP Capital
Ginette Depelteau	Same	Vice-President and Corporate Secretary

EX-99 5 g-c.htm EXHIBIT C EXHIBIT C

TABLE OF SALES
OF GENAISSANCE PHARMACEUTICALS, INC.

SALES

DATE

NUMBER OF
SHARES

PRICE PER
SHARE IN
CANADIAN DOLLARS

July 2002
03

September 2002
24

January 2003
07

100,000

15,000

12,500

1.02

0.52

1.02

Sales effected in United States

-----END PRIVACY-ENHANCED MESSAGE-----